Article
Washington - The optimum doses of biologic treatments for psoriasis may be higher than previously believed, according to Mark Lebwohl, M.D., professor and chairman, department of dermatology, Mt. Sinai School of Medicine.
Johnson & Johnson Submits 2 sBLAs for Guselkumab for Pediatric Psoriasis and Juvenile PsA
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology Insights
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Elimination Diets Have Little Impact on Pediatric Atopic Dermatitis, New Study Finds
Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis